Active substance
Urokinase
- US FDA 1
- UK MHRA 5
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| KINLYTIC | 250,000 IU/VIAL; 9,000 IU/VIAL; 5,000 IU/VIAL | injectable · injection | MICROBIX BIOSYSTEMS | Discontinued | 16 Jan 1978 |
UK MHRA United Kingdom — marketing authorisations
| Product | Authorisation | Holder | Legal status |
|---|---|---|---|
| SYNER-KINASE 10,000 IU POWDER FOR SOLUTION FOR INJECTION OR INFUSION | PL 20675/0006 | SYNER-MEDICA LIMITED | POM |
| SYNER-KINASE 100,000 IU POWDER FOR SOLUTION FOR INJECTION OR INFUSION | PL 20675/0002 | SYNER-MEDICA LIMITED | POM |
| SYNER-KINASE 25,000 IU POWDER FOR SOLUTION FOR INJECTION OR INFUSION | PL 20675/0001 | SYNER-MEDICA LIMITED | POM |
| SYNER-KINASE 250,000 IU POWDER FOR SOLUTION FOR INJECTION OR INFUSION | PL 20675/0003 | SYNER-MEDICA LIMITED | POM |
| SYNER-KINASE 500,000 IU POWDER FOR SOLUTION FOR INJECTION OR INFUSION | PL 20675/0004 | SYNER-MEDICA LIMITED | POM |
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), MHRA category lists of UK marketing authorisations (Open Government Licence v3.0), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.